Farah, Mohamed Guled <br/><br/>
Treatment outcome of new culture positive pulmonary tuberculosis in Norway.  [electronic resource] 

 -  BMC public health  Feb 2005 
 - 14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2458 
<br/><br/><label>Standard No.: </label>10.1186/1471-2458-5-14  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antitubercular Agents--pharmacology<br/>Child<br/>Child, Preschool<br/>Cohort Studies<br/>Drug Resistance, Microbial<br/>Drug Therapy, Combination<br/>Ethambutol--therapeutic use<br/>Female<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Isoniazid--pharmacology<br/>Male<br/>Middle Aged<br/>Mycobacterium tuberculosis--drug effects<br/>Norway--epidemiology<br/>Patient Compliance<br/>Pyrazinamide--therapeutic use<br/>Registries<br/>Rifampin--therapeutic use<br/>Treatment Failure<br/>Treatment Outcome<br/>Tuberculosis, Pulmonary--diagnosis